Tobacco smoking remains a leading cause of mortality and morbidity despite recent
declines in prevalence. In 2012, global prevalence rates for tobacco smoking were …

Despite extensive efforts to combat cigarette smoking/tobacco use, it still remains a leading
cause of global morbidity and mortality, killing more than eight million people each year …

Tobacco smoking among patients with psychiatric disease is more common than in the
general population, due to complex neurobiological, psychological, and …

Nicotine affects virtually all of the major neurotransmitter systems by its actions at nicotine
cholinergic receptors which are widely distributed in the brain. Patients suffering from …

Purpose of review: To provide an overview of the underlying neurobiology of tobacco
smoking in schizophrenia, and implications for treatment of this comorbidity. Recent findings …

Compared to the substantial volume of research on the general health consequences
associated with chronic smoking, little research has been specifically devoted to the …

Researchers interested in investigating the possible therapeutic effects and the mechanisms
of action of nicotine in neuropsychiatric disorders face a social–scientific–ethical dilemma …

Cigarette smoking is strongly associated with psychotic disorders such as schizophrenia.
For several decades it was assumed that the relationship could be explained by reverse …

It has been recognised for many years that patients with psychiatric illnesses, especially
schizophrenia, smoke to excess. However, recently there has been a resurgence of interest …

Rates of substance-use disorders among psychiatric patients are consistently higher than in
the general population, yet there is no clear specificity to the relationship between types of …